August 6, 2019
Meet Mukesh Pandey, Ph.D. – developing a new drug to detect prostate cancer in its earliest stages
By Sharon Rosen
With a background in organic chemistry, Mukesh Pandey, Ph.D., initially planned to work in the pharmaceutical industry developing medications. But after completing a post-doctoral research fellowship in radiology at Harvard Medical School, he chose to focus his skills on improving imaging technologies to better detect the first signs of disease. Now he is a nuclear […]
Tags: #Center for Individualized Mediicine, #GA-68 radiotracer, biomarker, mayo clinic, Mayo Clinic Center for Individualized Medicine Biomarker Discovery Program, molecular imaging
January 3, 2019
Mayo Clinic discovers biological markers that could guide treatment for prostate cancer
Prostate cancer is the most common form of cancer in American men, other than skin cancer.* Statistics from the American Cancer Society show approximately 1 in 9 American men will be diagnosed with prostate cancer at some time in their lives. Mayo Clinic Center for Individualized Medicine-sponsored research released today may help families facing difficult […]
Tags: George Vasmatzis Ph.D., Gleason pattern 3 prostate cancer, John Cheville M.D., Mayo Clinic Center for Individualized Medicine, Mayo Clinic Center for Individualized Medicine Biomarker Discovery Program, Prostate Cancer
August 2, 2017
Expanding the search: genetic testing reveals new targets, treatment options for cancer patients
By Sharon Rosen
Researchers in Mayo Clinic Center for Individualized Medicine are using new genetic tests developed at Mayo Clinic to find more effective therapies for cancer patients who have not benefited from standard treatment and are running out of options. The new tests look at a broader range of genetic characteristics than many standard tests. As a […]
Tags: #3-d models, #boimarker, #CIMCon17, #DNA analysis, #Dr. Aaron Mansfield, #Dr. George Vasmatizis, #genetic variations, #liquid biopsies, center for individualized medicine, Genetic Testing, genomics, Lung Cancer